Toripalimab Plus Lenalidomide for Central Nervous System Recurrence in Refractory CD5+ Diffuse Large B-cell Lymphoma with MYD88 and CD79B Comutation: a Case Report.
Translational Cancer Research（2024）
Key words
Diffuse large B-cell lymphoma (DLBCL),central nervous system recurrence,toripalimab,MYD88 and CD79B mutations,case report
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined